Medicines Identified as Low Priority for Funding in NHS Wales – Paper 2

Source:
All Wales Medicines Strategy Group - AWMSG
Publisher:
All Wales Medicines Strategy Group (AWMSG)
Publication date:
01 December 2018

Abstract

Four medicines/medicine groups have been identified for the purposes of this document: omega-3 fatty acid compounds, oxycodone and naloxone combination product, paracetamol and tramadol combination product and perindopril arginine.